BATOUL TRADING LTD

Company number 13476580 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BATOUL TRADING LTD - Analysis Report

Company Number: 13476580

Analysis Date: 2025-07-29 15:06 UTC

Financial Health Assessment: BATOUL TRADING LTD (as of 30 June 2024)


1. Financial Health Score: C

  • Explanation: The company shows a moderate financial condition with positive net assets and shareholders’ funds; however, there are signs of declining liquidity and increased long-term liabilities, indicating some financial stress. The score reflects a business that is viable but exhibiting symptoms that warrant monitoring and corrective action.

2. Key Vital Signs

Metric 2024 Value Interpretation
Fixed Assets £9,193 Moderate level of long-term assets; slight decline from last year suggests asset disposals or depreciation.
Current Assets £2,540 Sharp decrease from £7,566 in 2023; may indicate reduced cash or receivables—a symptom of tightening liquidity.
Current Liabilities £4,000 Current liabilities higher than current assets, indicating potential short-term cash flow pressure.
Net Current Assets £1,812 Positive but significantly reduced from previous years. Indicates working capital is healthy but shrinking.
Total Assets Less CL £11,005 Decreased from £18,018 in 2023. Reflects overall asset base after deducting short-term debts.
Creditors Due After 1 Year £4,000 Long-term liabilities have decreased, but still significant; company has debt obligations beyond one year.
Net Assets (Shareholders Funds) £7,005 Positive and increased from previous year; shows accumulated equity and retained earnings improving.
Employee Count 2 Small workforce consistent with micro-entity status; limited fixed overheads.

Additional Observations:

  • Account category: Micro, indicating minimal filing requirements and a small-sized operation.
  • Industry: Wholesale of fruit and vegetables (SIC 46310) — a sector sensitive to inventory turnover and cash flow.
  • Director & Control: Single director with 75-100% ownership, implying centralized decision-making and control.

3. Diagnosis: Financial Health and Underlying Concerns

  • Healthy Equity Position: The company’s shareholders’ funds have increased from £2,018 in 2023 to £7,005 in 2024, indicating retained profitability or capital injection. This is a positive vital sign akin to having a robust immune system.

  • Liquidity "Symptom" Alert: The drop in current assets from £7,566 to £2,540 alongside current liabilities of £4,000 signals a liquidity tightening. This is like a patient whose blood pressure (cash flow) is dropping — warning of potential short-term distress. The net current assets remain positive at £1,812, but the sharp decline warrants attention.

  • Debt Reduction: Long-term liabilities have decreased substantially from £16,000 to £4,000, which is a positive sign of debt management and reducing financial burden.

  • Operational Scale Stable: Employee count steady at 2; no signs of expansion or contraction in workforce, indicating stable operational scale but limited capacity for growth.

  • Asset Management: Fixed assets have decreased, possibly due to disposals or depreciation, suggesting the company may be optimizing or downsizing physical resources.

  • Overall Picture: The company is stable but showing early symptoms of liquidity stress and reduced asset base. Although equity is improving, the reduced current assets relative to liabilities could impair day-to-day operations if not addressed.


4. Recommendations: Prescriptions for Financial Wellness

  • Improve Working Capital Management: Focus on accelerating receivables collection, optimizing inventory turnover, and negotiating better payment terms with suppliers to boost current assets and relieve liquidity pressure.

  • Monitor Cash Flow Closely: Implement regular cash flow forecasting to detect and address shortfalls early, ensuring a "healthy pulse" of incoming and outgoing funds.

  • Debt Management Strategy: Continue efforts to reduce long-term liabilities prudently to minimize interest burden and improve solvency.

  • Consider Capital Injection or Financing: If liquidity concerns persist, contemplate raising additional funds through equity or short-term financing to stabilize cash flow.

  • Operational Efficiency: Explore ways to enhance operational efficiency without increasing fixed costs, maintaining a lean structure aligned with micro-entity status.

  • Regular Financial Review: Schedule quarterly financial health check-ups to monitor vital signs and symptoms, enabling timely interventions.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.